Page last updated: 2024-10-31

midazolam and Catatonia

midazolam has been researched along with Catatonia in 6 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)

Research Excerpts

ExcerptRelevanceReference
"Benzodiazepine withdrawal-induced catatonia is a rare phenomenon in the adult population and has never been reported in a pediatric patient."5.46Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient. ( Duncan-Azadi, CR; Gormley, A; Johnson, PN, 2017)
"Benzodiazepine withdrawal-induced catatonia is a rare phenomenon in the adult population and has never been reported in a pediatric patient."1.46Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient. ( Duncan-Azadi, CR; Gormley, A; Johnson, PN, 2017)
"Catatonia is a well-described neuropsychiatric syndrome that has been the subject of several texts."1.37Cases of catatonia on an academic electroconvulsive therapy service: lessons to learn. ( Aloysi, AS; Kellner, CH; Popeo, DM, 2011)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Asada, R1
Hori, H1
Iida, H1
Kawasaki, H1
Mustafa, FA1
Duncan-Azadi, CR1
Johnson, PN1
Gormley, A1
Aloysi, AS1
Popeo, DM1
Kellner, CH1
Hyatt, M1
Braun, N1
Briscoe, G1
Dickson, L1
Masiar, SJ1

Other Studies

6 other studies available for midazolam and Catatonia

ArticleYear
Benzodiazepine withdrawal catatonia after discontinuing midazolam in young patient with intellectual developmental disorder: A case report.
    Asian journal of psychiatry, 2023, Volume: 89

    Topics: Adult; Benzodiazepines; Catatonia; Developmental Disabilities; Humans; Intellectual Disability; Male

2023
Intravenous Midazolam as a Diagnostic Test for Catatonia.
    The journal of ECT, 2017, Volume: 33, Issue:4

    Topics: Catatonia; Delayed Diagnosis; Electroconvulsive Therapy; Female; GABA Modulators; Hashimoto Disease;

2017
Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient.
    A & A case reports, 2017, May-01, Volume: 8, Issue:9

    Topics: Catatonia; Child; Drug Administration Schedule; Humans; Hypnotics and Sedatives; Infusions, Intraven

2017
Cases of catatonia on an academic electroconvulsive therapy service: lessons to learn.
    The journal of ECT, 2011, Volume: 27, Issue:3

    Topics: Aged; Aged, 80 and over; Anxiety Disorders; Catatonia; Depressive Disorder; Depressive Disorder, Maj

2011
The use of midazolam for hypnosedative interviews.
    General hospital psychiatry, 1993, Volume: 15, Issue:4

    Topics: Adult; Catatonia; Conscious Sedation; Conversion Disorder; Diagnosis, Differential; Humans; Intervie

1993
Failure to use ECT in treatment of catatonia.
    The American journal of psychiatry, 1992, Volume: 149, Issue:1

    Topics: Catatonia; Electroconvulsive Therapy; Female; Humans; Informed Consent; Midazolam; Treatment Refusal

1992